Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
2022 · New England Journal of Medicine · 910 citations
https://doi.org/10.1056/nejmoa2200075
S
Serigne Lo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
597
Papers
15.0K
Citations
59
h-index
200
i10-index
Serigne Lo is an academic researcher from The University of Sydney. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & Cancer Immunotherapy and Biomarkers & Melanoma and MAPK Pathways. The author has an h-index of 59, co-authored 508 publications.
ORCID: 0000-0001-5092-5544Papers by this author
worksLong-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors
2018 · Annals of Surgical Oncology · 174 citations
https://doi.org/10.1245/s10434-017-6325-1
Effect of a Computer-Guided, Quality Improvement Program for Cardiovascular Disease Risk Management in Primary Health Care
2015 · Circulation Cardiovascular Quality and Outcomes · 140 citations
https://doi.org/10.1161/circoutcomes.114.001235
Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
2017 · British Journal of Cancer · 100 citations
https://doi.org/10.1038/bjc.2017.142
Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial
2023 · The Lancet Digital Health · 66 citations
https://doi.org/10.1016/s2589-7500(23)00130-9
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study
2018 · Annals of Surgical Oncology · 59 citations
https://doi.org/10.1245/s10434-018-6470-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat